Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Julphar
Citi
Baxter
Express Scripts
Queensland Health
Fish and Richardson
Dow
McKesson
Moodys

Generated: October 19, 2017

DrugPatentWatch Database Preview

PROCARDIA XL Drug Profile

« Back to Dashboard

Which patents cover Procardia Xl, and when can generic versions of Procardia Xl launch?

Procardia Xl is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in PROCARDIA XL is nifedipine. There are thirty-nine drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the nifedipine profile page.

Summary for Tradename: PROCARDIA XL

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list8
Bulk Api Vendors: see list90
Clinical Trials: see list5
Patent Applications: see list8,786
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROCARDIA XL at DailyMed

Pharmacology for Tradename: PROCARDIA XL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
PROCARDIA XL
nifedipine
TABLET, EXTENDED RELEASE;ORAL019684-001Sep 6, 1989AB2RXYesNo► Subscribe► Subscribe► Subscribe
Pfizer
PROCARDIA XL
nifedipine
TABLET, EXTENDED RELEASE;ORAL019684-002Sep 6, 1989AB2RXYesNo► Subscribe► Subscribe► Subscribe
Pfizer
PROCARDIA XL
nifedipine
TABLET, EXTENDED RELEASE;ORAL019684-003Sep 6, 1989AB2RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PROCARDIA XL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
PROCARDIA XL
nifedipine
TABLET, EXTENDED RELEASE;ORAL019684-001Sep 6, 1989► Subscribe► Subscribe
Pfizer
PROCARDIA XL
nifedipine
TABLET, EXTENDED RELEASE;ORAL019684-003Sep 6, 1989► Subscribe► Subscribe
Pfizer
PROCARDIA XL
nifedipine
TABLET, EXTENDED RELEASE;ORAL019684-003Sep 6, 1989► Subscribe► Subscribe
Pfizer
PROCARDIA XL
nifedipine
TABLET, EXTENDED RELEASE;ORAL019684-001Sep 6, 1989► Subscribe► Subscribe
Pfizer
PROCARDIA XL
nifedipine
TABLET, EXTENDED RELEASE;ORAL019684-002Sep 6, 1989► Subscribe► Subscribe
Pfizer
PROCARDIA XL
nifedipine
TABLET, EXTENDED RELEASE;ORAL019684-003Sep 6, 1989► Subscribe► Subscribe
Pfizer
PROCARDIA XL
nifedipine
TABLET, EXTENDED RELEASE;ORAL019684-002Sep 6, 1989► Subscribe► Subscribe
Pfizer
PROCARDIA XL
nifedipine
TABLET, EXTENDED RELEASE;ORAL019684-001Sep 6, 1989► Subscribe► Subscribe
Pfizer
PROCARDIA XL
nifedipine
TABLET, EXTENDED RELEASE;ORAL019684-003Sep 6, 1989► Subscribe► Subscribe
Pfizer
PROCARDIA XL
nifedipine
TABLET, EXTENDED RELEASE;ORAL019684-001Sep 6, 1989► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
McKinsey
Chinese Patent Office
AstraZeneca
Covington
Argus Health
QuintilesIMS
Merck
Julphar
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot